PRTN3 and rheumatoid arthritis: In humans, autoantibodies against citrullinated antigens, known as anti‐citrullinated protein antibodies (ACPA), have been shown to be a marker of aggressive arthritis, predictive of erosive disease, and highly specific to RA 29, 30.